Development and validation of a machine learning model for early detection of melanoma using dermoscopic images and clinical metadata

Project Abstract

Early detection of melanoma significantly improves survival, yet clinicians face challenges in differentiating malignant lesions from benign nevi using dermoscopic images alone, especially in resource-limited settings. This study presents the development and validation of a multi-modal machine learning (ML) model that integrates high-resolution dermoscopic images with structured clinical metadata to enhance early melanoma identification. We curated a diverse dataset comprising dermoscopic images from multiple publicly available repositories and hospital databases, encompassing a wide range of lesion types, body sites, Fitzpatrick skin phototypes, and imaging conditions. Each case was annotated by expert dermatologists for ground truth diagnosis, and a standardized preprocessing pipeline was applied to address variations in illumination, color normalization, and scale. The ML framework employs a dual-branch architecture a convolutional neural network (CNN) backbone to extract rich visual representations from dermoscopic images and a gradient-boosting or transformer-based module to process clinical metadata such as patient age, sex, lesion location, lesion size, evolution, family history, and sun exposure history. Feature fusion occurs at later layers to produce a cohesive risk score. To mitigate class imbalance, we implemented data augmentation strategies for images and synthetic minority oversampling for metadata where appropriate. We compared several modeling approaches, including single-stream CNNs, metadata-enhanced CNNs, and fully multimodal architectures with attention mechanisms to capture inter-modal interactions. Model training utilized stratified k-fold cross-validation, with performance evaluated on hold-out test sets across external validation cohorts to assess generalizability. Evaluation metrics included area under the receiver operating characteristic curve (AUC-ROC), sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and calibration curves. We further analyzed model interpretability through Grad-CAM visualizations to identify salient dermoscopic features and SHAP values to quantify the contribution of clinical variables. Results demonstrate that the multimodal model outperforms image-only baselines, achieving a statistically significant increase in AUC-ROC and sensitivity without compromising specificity, particularly in early-stage melanomas (in situ and T1). The integration of clinical metadata improved calibration, enabling clinically actionable risk stratification thresholds. External validation on independent cohorts confirmed robust performance, with limited degradation across diverse imaging devices and demographics, indicating good generalizability. Subgroup analyses revealed consistent gains across Fitzpatrick skin types II–IV and lesions located on trunk and extremities, though performance variations were observed in pediatric populations, warranting targeted data collection. The study also explores deployment considerations, including computational efficiency, inference latency, and privacy-preserving data handling, to support real-time clinical decision support in dermatology clinics. Limitations include potential bias from retrospective data, reliance on accurate metadata entry, and the need for prospective multicenter trials to validate real-world utility. Overall, the proposed multimodal ML model demonstrates promise for improving early melanoma detection, enabling earlier intervention and potentially reducing unnecessary biopsies, while highlighting pathways for integration into routine dermatologic practice.

Project Overview

What This Project Is About

---

A plain-language overview of using computer-based methods to help doctors spot melanoma early. The project combines pictures of skin lesions (dermoscopic images) with basic patient information to train a simple computer program to tell which spots might be melanoma, so doctors can investigate sooner.

---

---

The Problem It Addresses

---

Early detection of melanoma saves lives, but it can be hard to tell risky spots from harmless ones using only eyes and experience. There is a need for a reliable, easy-to-use tool that combines image evidence with patient details to reduce missed cases and unnecessary biopsies.

---

---

Objectives of the Project

---

1. Understand how images and basic patient data can hint at melanoma risk.
2. Build a simple machine learning model that can classify lesions as high-risk or low-risk.
3. Test the model on real-world data to see how well it works.
4. Compare the model’s performance with standard clinical checks.
5. Explain the model’s predictions in a way doctors can trust.

---

---

What You Will Do Step by Step

---

Step 1: Learn basic concepts about skin cancer and dermoscopy (skin images used by dermatologists).

Step 2: Gather a small, anonymized data set of dermoscopic images and basic patient info.

Step 3: Preprocess images and data (cleaning, resizing, and labeling).

Step 4: Split data into training and testing groups, train a simple model, and tune it.

Step 5: Evaluate accuracy, sensitivity, and specificity; adjust approach if needed.

Step 6: Create a clear explanation of the model’s decisions for clinicians.

---

---

Expected Outcome

A practical, easy-to-use model that points out high-risk lesions using both images and patient data, with a straightforward explanation for clinicians and a plan for future improvement.